ERBB2 and breast carcinoma: Immunohistochemical and molecular expression profiles of key genes studies have classified breast cancer into four broad subtypes: estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), human epidermal growth factor receptor 2-positive (HER2+), and triple-negative [6].